Double-Blind Comparison Between Mitiglinide and Nateglinide in Type 2 Diabetic Patients

Multicentre, Double-Dummy, Randomized, Double-Blind Comparison Between Mitiglinide and Nateglinide in the Patients With Type 2 Diabetes

The purpose of this study is to evaluate the efficacy and safety of Mitiglinide compared to Nateglinide for the treatment of type 2 diabetes.

Inclusion Criteria:

• Type 2 diabetes patients with inadequate control of blood glucose with diet and/or exercise therapy

Exclusion Criteria:

• Type 1 diabetes patients
• Patients who require treatment with insulin
• Patients with severe diabetic complications (neuropathy, retinopathy or nephropathy)
• Patients with severe ketosis, diabetic coma or precoma
• Patients complicated with severe hepatic diseases
• Patients complicated with severe renal diseases
• Patients complicated with severe hypertension
• Patients complicated with severe cardiac disease
• Pregnant women or women possible to be pregnant, nursing women, or women who want to become pregnant during the study period